Century Therapeutics, Inc. (IPSC) — Stock Score Summary

Century Therapeutics, Inc. (IPSC) has a MoatMap StockRank of 57/100 based on Quality (34/100), Value (38/100), and Momentum (69/100) factor scores. The current signal is HOLD. Century Therapeutics is an early-stage cell therapy biotech. It is highly speculative, pre-revenue, and lacks any near-term commercialization or alignment with our CDMO pricing power theme.

Century Therapeutics, Inc. is a biotechnology company focused on developing allogeneic induced pluripotent stem cell (iPSC)-derived cell therapies for various cancers. Leveraging its proprietary iPSC platform, the company aims to create off-the-shelf, gene-edited cell therapies that can be administered to a broad patient population. This innovative approach positions Century as a key player in the emerging field of iPSC-based oncology treatments.

Key Financial Metrics

Price$2.07
Market Cap$430M
P/E (Forward)-4.81
Price/Book1.50
Return on Equity-42.7%
Return on Invested Capital-5.2%
Debt/Equity18.14
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-54M

Century Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Century Therapeutics, Inc.’s (IPSC) StockRank?
MoatMap’s StockRank for Century Therapeutics, Inc. (IPSC) is 57/100, with a Hold signal. It is a composite of Quality (34), Value (38), and Momentum (69) factor ranks across MoatMap’s 19,000+ stock universe.
Does Century Therapeutics, Inc. have an economic moat?
Century Therapeutics, Inc. (IPSC) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Century Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Century Therapeutics, Inc. (IPSC) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Century Therapeutics, Inc. in?
Century Therapeutics, Inc. (IPSC) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksIPSC deep dive reportAI ChampionsHow we score stocksSense-check another stock